Project Grant FA95502510315
- Trustees of Indiana University was awarded a $724,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to optimize muscle function in composite tissue injuries with segmental bone defects. The three-year award beginning May 1, 2023 will support Indiana University's research efforts to investigate medical solutions for battlefield injuries involving both soft tissue damage and bone loss. Through this funding,...
- The Defense Health Agency awarded a $1,489,868 Project Grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 30, 2025 to September 29, 2029, will support the "OVARIAN CANCER ACADEMY: ADVANCING OVARIAN CANCER RESEARCH THROUGH MENTORSHIP, NETWORKING, AND COLLABORATIONS" initiative. The project aims to transform healthcare for military...
- This $449,387 federal Project Grant award was provided by the Air Force Research Laboratory (AFRL) under the Air Force Defense Research Sciences Program (CFDA 12.800) to the Trustees of Indiana University (doing business as Indiana University) for a research project titled "UNIVALENT VERIFICATION OF PARAMETERIZED STRUCTURES". The award commenced on September 30, 2024 and is scheduled for completion by September 29, 2027. The project aims to maintain technological superiority for the...
- The Department of Defense has awarded a $377,000.00 Cooperative Agreement to the Trustees of Indiana University, doing business as Indiana University, under the Basic Scientific Research program (CFDA 12.431). The grant titled "AI-Enabled Security Orchestration, Automation, and Response System for Enhancing Cybersecurity in a Zero Trust Environment" will support fundamental research to expand scientific knowledge and capabilities in areas critical to national security, such as...
- The Trustees of Indiana University were awarded a $1.3 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to prevent post-traumatic epilepsy by inhibiting the initiation of innate immune reaction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
- This Project Grant award, with a total funding of $158,500.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports an investigation into redox signaling as a potential therapeutic target for malignant peripheral nerve sheath tumors (MPNST). The ultimate period of performance for this grant is from July 1, 2024 to June 30, 2026. The grant recipient is the Trustees of Indiana University, doing business as Indiana...
- The Defense Health Agency awarded a $435,782.00 Project Grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from January 1, 2025 to December 31, 2027, will support research to explore the effects of tranexamic acid (TXA) on the pulmonary endothelium after thoracic trauma, with the goal of preserving endothelial integrity. As a prominent public research...
- This $938,053 federal project grant awarded by the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The awardee, Trustees of Indiana University, will conduct this 4-year research project to advance scientific understanding and develop new treatment approaches for this condition affecting military service members and veterans....
- This federal Project Grant award of $749,378.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research by the Trustees of Indiana University, doing business as Indiana University, to investigate the systemic administration of STO-609 to prevent post-traumatic osteoarthritis in a translational porcine intraarticular fracture model. The project will run from August 1, 2025 to July 31, 2028. Indiana University, a prominent public...
- The Defense Health Agency awarded a $622,008 project grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on November 1, 2024, with a completion date of October 31, 2026, supports research on "The SAGA Complex as an Essential Regulator of Abnormal Transcription Through De Novo DNA Topology Interactions in Multiple Myeloma." This project grant aims to...
This $598,704.00 federal Project Grant was awarded by the Department of Defense (CFDA 12.431 - Basic Scientific Research) to the Trustees of Indiana University, doing business as Indiana University, on September 25, 2025. The grant supports a 3-year research project titled "OPTIMIZING MIND-BODY INTERACTIONS IN RESPIRATORY CONTROL DURING OPERATIONALLY RELEVANT ENVIRONMENTAL STRESSORS" with a completion date of September 24, 2028. The research aims to expand fundamental scientific knowledge and capabilities in areas critical to national security, such as quantum technologies, advanced materials, and biotechnology. As a prominent public research university, Indiana University will leverage its extensive expertise across scientific and technological domains to conduct this high-risk, high-payoff research initiative that could enhance military technological superiority.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $598.7k | 9/18/25 |